Parexel Industry Insights
-
Strategies To Win Breakthrough Designation In Rare Disease Programs
3/31/2026
Breakthrough designation can unlock faster paths for rare disease therapies. Learn how smart timing, compelling evidence, and early regulatory alignment can turn promising science into accelerated patient impact.
-
5 Strategies For Designing Successful Complex Rare Disease Trials
3/31/2026
Rare disease trials demand inventive design. Uncover creative strategies that help sponsors overcome tiny populations, complex endpoints, and operational hurdles to advance meaningful breakthroughs.
-
5 RWE Approaches That Strengthen Precision Oncology
3/31/2026
Real-world evidence is becoming vital in precision oncology. Discover five creative, practical ways sponsors can use RWE to fuel development, sharpen regulatory strategy, and strengthen market access.
-
Accelerating Oncology Drug Development Through Innovative Designs
3/30/2026
Adaptive and novel trial designs are redefining oncology development, powering faster decisions with smarter flexibility. Discover innovative approaches that elevate efficiency while safeguarding scientific rigor.
-
Mastering Precision Oncology Start-Up: Reducing Screening Delays
3/30/2026
Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.